Session Information

Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.

Subject:

Date:
Thursday, August 16

CME Credits:
1.50

Location:
Room 206

Time:
1:00 PM - 2:30 PM

Director:
Jeffrey J. Meffert, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

Compare the different types of pharmaceutical advertising according to FDA standards

Describe the process for reporting suspected marketing violations

Distinguish "proper" from "improper" advertisements

Description:
While the FDA does not pre-approve pharmaceutical advertising, they have established several categories of advertisements and set policies for what is "appropriate" and allowed in each one. Unfortunately these are often ignored. Physicians and patients make unwarranted assumptions about what "FDA approved" means for safety and efficacy when applied to over the counter medications and devices. Procedures exist for reporting of inappropriate advertising or unethical marketing practices, such reports sometimes resulting in multi-million dollar fines for the companies involved.